Beth Snyder Bulik

After two years of turmoil, Outcome Health is done with its apology tour and ready to debut its change-agent strategy.

Pharma marketers should add bias to their digital strategies—brand bias, that is, CMI/Compas says.

Physicians are seeing fewer pharma sales reps than ever, which likely isn’t a surprise. But digital contact by reps isn’t taking up the slack.

Former NFL star Terry Bradshaw is reaching out to fellow boomers about the risk of pneumococcal pneumonia in Pfizer’s latest awareness push.

Novartis’ new collab with Microsoft leverages AI to streamline drug discovery, but the joint effort goes beyond just finding new treatments.

It’s a repeat offense for Galt Pharmaceuticals' Doral. The FDA's ad watchdog slapped Galt with a warning letter about an email that omits drug risks.

Veeva Systems is buying Crossix Solutions with an eye to integrating the Veeva HCP cloud software services with Crossix data and analytics.

Four of the top 10 companies on the Working Mother "100 Best Companies" annual list are pharma companies.

AstraZeneca is enlisting artificial intelligence to coach its sales reps using data generated from thousands of field-coaching forms.

Hypoglycemia is a consistent concern for people with diabetes. But the families of Type 1 and Type 2 patients also worry, Novo Nordisk's new survey shows.